Placebo Optimization of the Presurgical Long-term Video-EEG Monitoring
NCT06383689 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2024-06-10
Summary
The notion of genuine placebo effects on epileptic seizure events (i.e., effects beyond methodological study artifacts) is incompatible with the standard model of epilepsy seizure genesis. In this single-blind controlled study, the effectiveness of a covered placebo on (1) the timing of the occurrence of a first epileptic seizure ("seizure pill") versus (2) the subjective well-being ("comfort pill") during pre-surgical video-EEG monitoring will be examined. It is hypothesized that a placebo effect on subjective well-being can be demonstrated, but that epileptic seizure events are not influenced by placebo.
Conditions
- Symptomatic Epilepsy
Interventions
- OTHER
-
Seizure placebo pill
patients in this study arm receive a covered placebo pill on a daily basis (1-0-1) with the indication of possible acceleration of seizure occurrence during presurgical video-EEG
- OTHER
-
Well-being placebo pill
patients in this study arm receive a covered placebo pill on a daily basis (1-0-1) with the indication of possible improvement of emotional well-being during video-EEG
Sponsors & Collaborators
-
University Hospital, Bonn
lead OTHER
Principal Investigators
-
Rainer Surges, Prof. · Department of Epileptology, University Hospital Bonn, Germany
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-13
- Primary Completion
- 2026-04-30
- Completion
- 2026-12-31
Countries
- Germany
Study Locations
More Related Trials
-
A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
NCT04241965 ·Status: COMPLETED ·Phase: PHASE1
-
Pregabalin Open-Label Extension Trial in Patients With Partial Seizures
NCT00143143 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
NCT00141414 ·Status: COMPLETED ·Phase: PHASE2
-
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
NCT00043914 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
NCT00228969 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00150293 ·Status: COMPLETED ·Phase: PHASE3
-
PRX-00023 Therapy in Localization-Related Epilepsy
NCT01281956 ·Status: TERMINATED ·Phase: PHASE2
-
Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation
NCT02305329 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Perampanel on Neurophysiology Test Perimeters
NCT03653741 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients
NCT03239691 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study
NCT06736002 ·Status: RECRUITING ·Phase: NA
-
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures
NCT00141388 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093
NCT02170077 ·Status: COMPLETED ·Phase: PHASE2
-
A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
NCT01618695 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
NCT04252846 ·Status: COMPLETED
-
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
NCT00407797 ·Status: TERMINATED ·Phase: PHASE4
-
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
NCT06908356 ·Status: RECRUITING ·Phase: PHASE2
-
A Trial of Generic Substitution of Antiepileptic Drugs
NCT02429596 ·Status: UNKNOWN ·Phase: PHASE4
-
Premenstrual Dysphoric Disorder and Antiepileptic Drugs
NCT00612235 ·Status: COMPLETED
-
A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093
NCT02171234 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Impact of Benzodiazepin Withdrawn After Curative Epilepsy Surgery in Children With Focal Epilepsy
NCT03803046 ·Status: TERMINATED
-
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00141336 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
NCT02834793 ·Status: TERMINATED ·Phase: PHASE3
-
Role of Clinical Pharmacists in Epilepsy Management
NCT04967326 ·Status: COMPLETED ·Phase: PHASE4